Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Gastrointestinal 1Endocrine 1Classical hematology 1

Conditions

Ulcer 1Stomatitis 1Stomach Neoplasms 1Speech 1Radiation Injuries 1Pain 1Neuroendocrine Tumors 1Mucositis 1Head and Neck Neoplasms 1Anemia, Iron-Deficiency 1

Interventions

lutetium Lu 177 dotatate 34Everolimus 33lanreotide 13gallium Ga 68 dotatate 13Temozolomide 13Magnetic Resonance Spectroscopy 13Nivolumab 12pembrolizumab 11Octreotide 11Capecitabine 11177Lu-octreotide, DOTA(0)-Tyr(3)- 10cabozantinib 9Positron Emission Tomography Computed Tomography 93-Iodobenzylguanidine 9surufatinib 8Sunitinib 8Specimen Handling 7Carboplatin 7pasireotide 6amino-acid, glucose, and electrolyte solution 690Y-octreotide, DOTA-Tyr(3)- 6lenvatinib 5Lutetium-177 5Ipilimumab 5Fluorodeoxyglucose F18 5Etoposide 5Cisplatin 5Bevacizumab 5telotristat ethyl 4olaparib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neuroendocrine Tumors × Betaine × Clear all
NCT06881511 2025-03-30

Exploratory Study on the Efficacy of Betaine Hydrochloride in Treating Autoimmune Gastritis

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase NA Recruiting
100 enrolled
Classical hematologyEndocrineGastrointestinalNET

Stomach Neoplasms, Neuroendocrine Tumors, Anemia, Iron-Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡